Rehabilitation · Products

Deyee SHOCKWAVE DY-C1

The Deyee SHOCKWAVE DY-C1 combines robotic precision with extracorporeal shockwave therapy (ESWT) technology to deliver targeted mechanical stimulation for deep tissue treatment. Developed by Deyee Healthcare Robot, this system automates shockwave application while integrating AI algorithms for treatment personalization and consistent therapeutic delivery across rehabilitation and wellness settings.

Product Overview

Shockwave therapy uses high-energy acoustic waves to stimulate tissue repair and reduce pain through mechanical and biological mechanisms. The DY-C1 integrates this established therapeutic modality with robotic delivery, addressing the variability and physical demands associated with manual shockwave application.

The system targets healthcare facilities seeking to expand shockwave therapy capacity while maintaining treatment consistency. By automating probe positioning and pressure application, the DY-C1 reduces operator dependence and enables practitioners to manage multiple treatment sessions more efficiently.

Key Features

Robotic Shockwave Delivery: A multi-axis robotic arm positions the shockwave applicator with mechanical precision, maintaining consistent contact pressure and treatment angles throughout sessions. This addresses a common challenge in manual ESWT where operator fatigue can affect treatment quality.

AI Treatment Adaptation: Algorithms analyze patient parameters and treatment responses to adjust shockwave intensity, frequency, and targeting. The system can be programmed with treatment protocols for specific conditions while allowing real-time modifications based on patient feedback.

Deep Tissue Penetration: The shockwave mechanism delivers mechanical stimulation that penetrates beyond superficial tissues to reach deeper muscle layers, tendons, and connective structures where many chronic pain conditions originate.

Multi-Area Treatment Support: The robotic platform accommodates treatment of various anatomical regions including shoulders, back, hips, knees, and extremities, with positioning capabilities that adapt to different body contours.

Technical Specifications

Deyee’s DY-C1 delivers radial or focused shockwave via a multi-axis robotic arm with AI-assisted intensity control and cloud platform integration, addressing operator fatigue that limits consistency in manual ESWT.

ParameterSpecification
Therapy TypeRadial/Focused Shockwave
Robotic ArmMulti-axis positioning system
ControlAI-assisted with manual override
ConnectivityCloud platform integration
ApplicationsRehabilitation, pain management, wellness

Clinical Applications

The DY-C1 addresses several clinical scenarios where shockwave therapy has demonstrated utility:

Musculoskeletal Pain: Chronic conditions including plantar fasciitis, tennis elbow, shoulder impingement, and myofascial pain syndromes respond to controlled acoustic wave stimulation that promotes tissue healing and pain modulation.

Soft Tissue Rehabilitation: Post-injury recovery protocols benefit from shockwave therapy’s ability to stimulate circulation, enhance collagen production, and accelerate tissue repair processes.

Chronic Inflammation Management: The mechanical stimulation triggers biological responses that can reduce chronic inflammatory conditions, particularly in tendon and joint-related pathologies.

Sports Medicine: Athletic recovery and injury prevention programs incorporate shockwave therapy for muscle conditioning, trigger point treatment, and accelerated return-to-activity timelines.

Regulatory Status

RegionStatus
China (NMPA)Deployment reported in clinical settings; specific certification status to be confirmed
CE (Europe)Not confirmed
FDA (US)Not confirmed

Frequently Asked Questions

How does the DY-C1 differ from handheld shockwave devices?

The DY-C1 provides robotic automation of shockwave delivery, eliminating operator fatigue and ensuring consistent treatment parameters. Unlike handheld devices requiring continuous manual operation, the robotic system maintains precise positioning and pressure throughout extended treatment sessions while the AI component enables personalized protocol adjustments.

What conditions can the DY-C1 treat?

The system targets musculoskeletal conditions commonly treated with ESWT including chronic tendinopathies, myofascial pain, muscle injuries, and inflammatory conditions. Specific applications include plantar fasciitis, shoulder calcific tendinitis, lateral epicondylitis (tennis elbow), and various soft tissue injuries requiring rehabilitation support.

Is the treatment painful?

Shockwave therapy typically produces a sensation of pressure and mild discomfort at the treatment site, though intensity can be adjusted based on patient tolerance. The DY-C1’s AI control allows gradual intensity progression and real-time adjustment, enabling practitioners to optimize therapeutic effect while managing patient comfort.

Last modified: January 16, 2026

Sources

Publicly available references used for the data on this page. See data methodology for verification standards.